Related references
Note: Only part of the references are listed.Multiple sclerosis disease progression: Contributions from a hypoxia-inflammation cycle
Runze Yang et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
Xiaohui Qiu et al.
FRONTIERS IN NEUROLOGY (2019)
The energetic brain - A review from students to students
Melina Paula Bordone et al.
JOURNAL OF NEUROCHEMISTRY (2019)
\The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
Silvia Cerri et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease
Marthe H. R. Ludtmann et al.
NATURE COMMUNICATIONS (2018)
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease
Paula Perez-Pardo et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Lactate potentiates angiogenesis and neurogenesis in experimental intracerebral hemorrhage
Jing Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats
Tarek K. Motawi et al.
MOLECULAR NEUROBIOLOGY (2017)
Haloperidol induced Parkinson's disease mice model and motor-function modulation with Pyridine-3-carboxylic acid
Atif Saeed et al.
BIOMEDICAL RESEARCH AND THERAPY (2017)
Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review
Xin-Shi Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Role of Niacin in Current Clinical Practice: A Systematic Review
Aakash Garg et al.
AMERICAN JOURNAL OF MEDICINE (2017)
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity
Jing Lu et al.
PLOS ONE (2016)
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease
Santiago Perez-Lloret et al.
NPJ PARKINSONS DISEASE (2016)
Expression of key executioner of apoptosis caspase-3 in periodontal health and disease
Avani R. Pradeep et al.
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (2016)
Trends in inpatient antiparkinson drug use in the USA, 2001-2012
James A. G. Crispo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation
W. Michael Zawada et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
Hideyuki Sawada et al.
PLOS ONE (2015)
Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages
Kenneth R. Feingold et al.
JOURNAL OF LIPID RESEARCH (2014)
A novel treatment target for Parkinson's disease
Chandramohan Wakade et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinsn's Disease Progression and Related Dementia
Yaroslau Compta et al.
NEURODEGENERATIVE DISEASES (2014)
The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages
Mahbubur Rahman et al.
NATURE COMMUNICATIONS (2014)
Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra
Pablo Garrido-Gil et al.
BRAIN STRUCTURE & FUNCTION (2013)
ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Teng Jiang et al.
CURRENT NEUROPHARMACOLOGY (2013)
Istradefylline: First Global Approval
Rosselle Dungo et al.
DRUGS (2013)
Caudo-rostral brain spreading of α-synuclein through vagal connections
Ayse Ulusoy et al.
EMBO MOLECULAR MEDICINE (2013)
Parkinson disease: from pathology to molecular disease mechanisms
David T. Dexter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Renoprotective effect of the antioxidant curcumin: Recent findings
Joyce Trujillo et al.
REDOX BIOLOGY (2013)
Adenosine A2A receptor gene disruption protects in an a-synuclein model of Parkinson's disease
Anil Kachroo et al.
ANNALS OF NEUROLOGY (2012)
The Effect of Curcumin on the Stability of Aβ Dimers
Li Na Zhao et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2012)
Niaspan increases axonal remodeling after stroke in type 1 diabetes rats
Tao Yan et al.
NEUROBIOLOGY OF DISEASE (2012)
PROTECTIVE ROLE OF SELENIUM AGAINST OVER-EXPRESSION OF CANCER-RELATED APOPTOTIC GENES INDUCED BY O-CRESOL IN RATS
Wagdy K. B. Khalil et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2011)
Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats
Xinchun Ye et al.
EXPERIMENTAL NEUROLOGY (2011)
Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration
Yin-Meng Tsai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Neuropathy in Parkinson disease Prevalence and determinants
Yusuf A. Rajabally et al.
NEUROLOGY (2011)
Serial cytokine levels during wound healing in rabbit maxillary sinus mucosa
Xicai Sun et al.
ACTA OTO-LARYNGOLOGICA (2010)
The Acute Phase Response in the Rodenta
GERHARD SCHREIBER et al.
Annals of the New York Academy of Sciences (2010)
Behavioral phenotyping of mouse models of Parkinson's disease
Tonya N. Taylor et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Angiotensin II revisited: new roles in inflammation, immunology and aging
Ariela Benigni et al.
EMBO MOLECULAR MEDICINE (2010)
Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats
K. H. Reeta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron POTENTIAL ETIOLOGICAL LINKAGE TO NEURODEGENERATIVE DISEASES
Muralidhar L. Hegde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
Impaired Neurotransmitter Release in Alzheimer's and Parkinson's Diseases
Jie Shen
NEURODEGENERATIVE DISEASES (2010)
High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio
Jaime M. Ross et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Neuropothological assessment of Parkinson's disease: refining the diagnostic criteria. (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
The Effects of Exercise-induced Fatigue on Acetylcholinesterase Expression and Activity at Rat Neuromuscular Junctions
Guo Wen et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
Interleukin-6 Serum Levels in Patients with Parkinson's Disease
Kerly Wollmeister Hofmann et al.
NEUROCHEMICAL RESEARCH (2009)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Dennis W. Dickson et al.
LANCET NEUROLOGY (2009)
DNA damage and repair: Relevance to mechanisms of neurodegeneration
Lee J. Martin
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice
A. Rajeswari et al.
INFLAMMOPHARMACOLOGY (2008)
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation
Asha Jacob et al.
PPAR RESEARCH (2007)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Neuroinflammatory processes in Parkinson's disease
EC Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2005)
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats
M Alam et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C
MJ Chapman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
F Calon et al.
BRAIN (2004)
DNA damage in brain cells of mice treated with an oxidized form of apomorphine
JN Picada et al.
MOLECULAR BRAIN RESEARCH (2003)
Participation of the conventional calpains in apoptosis
T Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
A Ascherio et al.
ANNALS OF NEUROLOGY (2001)
Adenosine/dopamine interaction:: implications for the treatment of Parkinson's disease
S Ferré et al.
PARKINSONISM & RELATED DISORDERS (2001)
Share Paper
